Short answer: In 2026, the most profitable 3D printing businesses mostly do not sell 3D printers. Margins concentrate in four models: treatments with printing built in (Align Technology, hearing aids, etc.), medical software and services (Materialise Medical), ecosystems that sell recurring consumables (Formlabs), and devices priced on clinical value (FDA-cleared implants). Industrial printer hardware remains the least profitable part of the industry. A note on scope: this analysis leans toward the medical sector. That is 3DHEALS’ focus, and it is also where the margin evidence points. Industrial and consumer companies appear mainly for comparison.
Is the 3D printing industry profitable in 2026?
The industry feels better than it did a year ago. The German engineering association VDMA published its autumn 2026 survey on October 19. It found that 64% of German additive manufacturing firms grew sales over the past twelve months, up from 45% in fall 2025. Only 15% reported declining sales, down from 29%. Two-thirds expect market growth over the next two years, and 94% plan to hold or increase investment.
But growth is not profit. The same survey ranks costs (57%) and process stability (50%) among the industry’s top concerns. VDMA’s own reading is careful: it is “premature to speak of a fundamental trend reversal.” The survey also notes that additive manufacturing is spreading fastest in aviation and medical technology. That second point matters more than the first.
Why do most 3D printer manufacturers lose money?
Look at the listed printer makers. In the second quarter of 2026, Stratasys reported $137.6M in revenue, a 47.2% adjusted gross margin, and a GAAP net loss of $16.9M. Its adjusted operating margin was close to zero. 3D Systems reported $94.6M in revenue, a 36.7% adjusted gross margin and a $12.9M net loss. Healthcare is now about half of 3D Systems’ revenue and was its growing part, up about 7%.
Consumer hardware is no easier. Creality grew first-half revenue 12.9% and still swung to a net loss of RMB 59.1M, as price cuts pushed its gross margin from 34.4% to 30.8%. China’s Bright Laser Technologies stayed profitable, but its net profit fell 33% in the first half.
Meanwhile, hardware keeps getting cheaper. This week UC Berkeley released OpenCAL, an open-source volumetric printer built from about $1,638 in parts, with resin supplied through Formlabs and Prusa.
When a capable printer costs less than a laptop, selling printers alone is a hard way to earn a margin. The trend of continued commoditization and maturing market works for the consumers but not so much for OEMs.
Do digital manufacturers like Xometry and Proto Labs make money?
Xometry and Proto Labs sell parts, not printers, and both route work through printing, machining and molding capacity. Their results sit between the printer makers and the medical leaders.
Xometry grew second-quarter revenue 41% to $229.3M, with a 38.0% gross margin and a 6.2% adjusted EBITDA margin. It still posted a GAAP net loss of $5.3M. Its quarterly filing shows where the margin sits: the marketplace earns a 34.7% gross margin, while its smaller Thomas advertising and services business earn about 88%. Matching buyers to machines pays less than selling ads to suppliers.
Proto Labs is the steadier earner. Second-quarter revenue rose 10.6% to a record $149.3M, with a 46.4% GAAP gross margin, a 7.6% GAAP operating margin and $9.2M of net income. But printing is not what drove it. 3D printing revenue fell 2.7% in constant currency to $20.7M, while CNC machining and injection molding each grew about 13%.
Owning the customer and the quoting software earns a modest margin. The printing step itself does not. Neither company is a medical specialist, and neither earns medical-device pricing.
How does 3D printing profitability compare with other industries?
Benchmarks help separate a 3D printing problem from an ordinary manufacturing problem. The table sets second-quarter 2026 company results against US sector margins compiled by NYU Stern’s Aswath Damodaran in January 2026. Sector figures are trailing aggregates for US-listed companies; company figures are single quarters, so read the comparison as directional.
| Company or category | Gross margin | Net margin | Basis |
| Medical devices (US healthcare products) | 54.0% | 9.6% | Sector, 204 firms |
| Align Technology (dental device) | 71.7% | 10.3% | Q2 2026, GAAP |
| Stryker (orthopaedic implants) | 68.3% | ≈19% | Q2 2026, GAAP |
| Materialise | 56.8% | 4.8% | Q2 2026, IFRS |
| Industrial machinery makers (US sector) | 37.5% | 10.6% | Sector, 105 firms |
| Stratasys (printer maker) | 47.2% | −12.3% | Q2 2026, adj. gross |
| 3D Systems (printer maker) | 36.7% | −13.6% | Q2 2026, adj. gross |
| Manufacturing average | 33.6% | 7.2% | 27 subsectors |
| Proto Labs (digital manufacturing) | 46.4% | 6.1% | Q2 2026, GAAP |
| Xometry (manufacturing marketplace) | 38.0% | −2.3% | Q2 2026, GAAP |
Two patterns stand out. First, medical device makers as a group earn a 54% gross margin, well above industrial machinery makers at about 37% and the manufacturing average at about 34%. Align, Stryker, and Materialise’s medical segment with its 31.3% adjusted EBITDA margin, sit at or above that medical benchmark.
Second, the printer makers’ gross margins look like a machinery maker’s, but their net margins do not. US machinery companies net about 10.6% of sales. Stratasys and 3D Systems lose 12% to 14%. They have machine-maker pricing without machine-maker scale. Proto Labs, at 6.1% net, is close to the manufacturing norm; Xometry is approaching breakeven.
This analysis shows the 3DP advantage leans toward medicine. It is the one category where 3D printing companies beat their sector benchmark instead of trailing it.
Which 3D printing business models make money?
The profits sit outside of the printer. Four categories stand out.
1. Treatments with printing inside
Align Technology may be the most profitable 3D printing operation in the world, though it never markets itself that way. It prints a custom mold for every Invisalign aligner, about a million custom parts a day. Its Clear Aligner segment was $870.9M, about 82% of revenue, in Q2 2026. The company posted a 71.7% gross margin and $108M in net income. Align bought Cubicure in 2024 to print aligners directly, which could remove the mold step altogether.
Hearing aids follow the same pattern. Custom in-ear shells are routinely 3D printed, and privately held WS Audiology reported a 19.1% EBITDA margin in its latest quarter. In both cases the patient buys a treatment. The printer is a cost line, not the product.
2. Medical software and services
Materialise shows the gap inside a single company. Its medical segment earned a 31.3% adjusted EBITDA margin on €36.9M of revenue in Q2 2026, growing 12%. The company as a whole earned a 5.5% adjusted EBIT margin. Regulated medical software and patient-specific services are worth more than general printing capacity.
Services also win on throughput. HP reports that orthotics maker iOrthotics grew from about 30 devices a day to more than 100 pairs after moving to a digital, printed workflow. These are company-reported figures, but the logic is clear: once the workflow is digital, volume drives margin.
3. Ecosystems that sell consumables
Formlabs, which is private, says it has been profitable for more than two years, with free cash flow above 10% on more than $250M of 2025 revenue. Its printers lock in sales of its own resins. At Creality, consumables grew 48% while printer sales were flat. Bambu Lab is reported to have passed RMB 10B in 2025 revenue, though it does not disclose profit.
Dental shows the model clearly. This week SprintRay added an intraoral scanner and a compact chairside print-wash-cure line to its platform, and GC launched a hybrid ceramic resin for its Midas press. Pharmacy is next: PharmaTher is building a network of CraftMake printers in compounding pharmacies, a model we examined in last week’s issue and in our updated 3D Printed Drugs Guide.
4. Devices priced on clinical value
FDA-cleared implants are priced on outcomes, not on print time. This week Providence Medical Technology received 510(k) clearance for a 3D printed porous titanium cervical system. Implant pricing reflects clinical value and reimbursement, not material cost.
Stryker shows what that pricing is worth. It has printed more than two million porous titanium Tritanium implants since 2013, across knees, hips and spinal cages. Stryker does not report a separate margin for printed implants, but its Orthopaedics segment, where 3D printing sits, earned a 34.0% operating margin on about $3.0B of sales in Q2 2026. That is roughly twice the 15.3% operating margin of the average US healthcare products company. Company-wide, Stryker reported a 68.3% gross margin and about $1.3B in net earnings on $6.6B of sales. The printing is invisible in the accounts. The clinical value is not.
Printing can cut prices too. San Diego’s Limber Prosthetics sells a one-piece printed leg from $3,000, scanned with a smartphone and printed in about 12 hours. That is good for patients and payers. For the business, it means margin depends on volume and on who pays.
What should founders and investors take from this?
Margin follows the patient, not the machine. Three practical rules follow.
- Price the outcome, not the print. Sell a treatment, a finished part or a cleared device.
- Own the consumable. Validated materials and software create recurring revenue that hardware alone does not.
- Secure payment early. A better device is not automatically a billable one.
This is why Trio Labs sells finished, micron-scale metal parts for medical devices instead of printers. Founder Adam Steege explains when printing beats CNC machining and metal injection molding on Lattice Podcast Episode 130. On reimbursement, read our analysis Better Isn’t Billable and listen to Naomi Nathan of Mobility Goes Additive on Episode 129.
Frequently asked questions
Are 3D printing companies profitable?
Most listed printer manufacturers, including Stratasys and 3D Systems, reported net losses in Q2 2026. Companies that embed printing in a medical product or sell recurring materials, such as Align Technology and Formlabs, are profitable.
What is the most profitable use of 3D printing?
Mass-customized medical and dental products. Align’s clear aligners, built on 3D printed molds, carry a 71.7% gross margin.
Is selling 3D printers a good business?
Rarely on its own. Printer prices keep falling, and margins come from consumables, software and services sold alongside the hardware.
Are Xometry and Proto Labs profitable?
Proto Labs is, with $9.2M of net income and a 7.6% operating margin in Q2 2026. Xometry is close: positive adjusted EBITDA, but still a small GAAP net loss. Both earn far less than medical device makers.
Which business model would you back? Email: info@3dheals.com, and tell us, and subscribe to The Lattice Brief for weekly analysis.
Company figures link to SEC filings or investor-relations releases where available; other figures are from press and the Damodaran sector dataset. This is not audited analysis. This is not investment advice.
Comments